Cite
MLA Citation
Aya Nakaya et al.. “Delayed HBV reactivation in rituximab-containing chemotherapy: How long should we continue anti-virus prophylaxis or monitoring HBV-DNA?.” Leukemia research, vol. 50, n.d., pp. 46–49. http://access.bl.uk/ark:/81055/vdc_100038845868.0x00002e